TORONTO, Nov. 14 /CNW/ - Transition Therapeutics Inc. ("Transition" or
the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical
company developing therapeutics for disease indications with large markets,
today announced its financial results for the quarter ended September 30,
2007.
